SEC Comment Letter for BIOLARGO, INC. (BLGO) (CIK 0000880242) (BLGO) — Jun 7, 2017
BIOLARGO, INC. (BLGO) (CIK 0000880242)
Date: June 7, 2017 · CIK: 0000880242 · Accession: 0000000000-17-019909
AI Filing Summary & Sentiment
Reasoning
Referenced dates: June 2, 2017
Letter
Mailstop 4631 June 7 , 2017 Dennis P. Calvert Chief Executive Officer BioLargo, Inc. 14921 Chestnut St. Westminster, CA 92683
Re: BioLargo, Inc. Amendment No. 4 to Registration Statement on Form S -1 Filed June 5 , 2017 File No. 333 -215730
Dear Mr. Calvert :
We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may bette r understand your disclosure.
Please respond to this letter by amending your registration statement and providing the requested information . If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments.
Capitalization, page 11
1. We have reviewed your response to comment one in our letter June 2, 2017 . The total amount of the items you present as current liabilities as of March 31, 2017 is $933,498 and not $696,79 9. It appears you may have incorrectly presented deposits of $236,699 as of March 31, 2017. Please revise and ensure that the total amount of the items you present as current liabilities here agrees to the amount of current liabilities as presented on yo ur balance sheet.
Dilution, page 11
2. We have reviewed your response to comment two in our letter dated June 2, 2017 . It appears your net tangible book value per share of common stock as of March 31, 2017 was actually $(0.017). Please revise or advise.
Dennis P. Calvert BioLargo, Inc. June 7 , 2017 Page 2
We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Refer to Rules 460 and 461 regarding requests for accele ration . Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement.
You may contact Jeffrey Gordon, Staff Accountant at (202) 551 -3866 or John Cash, Accounting Branch Chief at (202) 551-3768 if you have questions regarding comments on the financial statements and related matters. You may contact Kate McHale, Staff Attorney at (202) 551-3464 or me at (202) 551 -3397 with any other questions.
Sincerely,
/s/ Jay Ingram
Show Raw Text
Mailstop 4631 June 7 , 2017 Dennis P. Calvert Chief Executive Officer BioLargo, Inc. 14921 Chestnut St. Westminster, CA 92683 Re: BioLargo, Inc. Amendment No. 4 to Registration Statement on Form S -1 Filed June 5 , 2017 File No. 333 -215730 Dear Mr. Calvert : We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may bette r understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information . If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Capitalization, page 11 1. We have reviewed your response to comment one in our letter June 2, 2017 . The total amount of the items you present as current liabilities as of March 31, 2017 is $933,498 and not $696,79 9. It appears you may have incorrectly presented deposits of $236,699 as of March 31, 2017. Please revise and ensure that the total amount of the items you present as current liabilities here agrees to the amount of current liabilities as presented on yo ur balance sheet. Dilution, page 11 2. We have reviewed your response to comment two in our letter dated June 2, 2017 . It appears your net tangible book value per share of common stock as of March 31, 2017 was actually $(0.017). Please revise or advise. Dennis P. Calvert BioLargo, Inc. June 7 , 2017 Page 2 We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for accele ration . Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. You may contact Jeffrey Gordon, Staff Accountant at (202) 551 -3866 or John Cash, Accounting Branch Chief at (202) 551-3768 if you have questions regarding comments on the financial statements and related matters. You may contact Kate McHale, Staff Attorney at (202) 551-3464 or me at (202) 551 -3397 with any other questions. Sincerely, /s/ Jay Ingram Jay Ingram Legal Branch Chief Office of Manufacturing and Construction